This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA)

This study is ongoing, but not recruiting participants.
Sahlgrenska University Hospital, Sweden
Göteborg University
Information provided by (Responsible Party):
Integrum Identifier:
First received: October 15, 2012
Last updated: November 13, 2012
Last verified: November 2012

Patients with transfemoral amputations (TFA) frequently experience problems related to the use of socket-suspended prostheses 1-3. These problems increase with short or deformed stumps 4. The potential for improvement is substantial. Based on the very good long-term results with osseointegrated titanium implants for edentulous patients 5, osseointegrated hearing aids 6, cranio-facial prostheses 7 and prostheses for thumb-amputated patients 8, the clinical development of osseointegrated prostheses for TFA started in 1990, in Gothenburg, Sweden. The concept has gradually been modified and improved. In 1999, a prospective clinical trial began.

The hypothesis is that the treatment will improve quality of life.

Condition Intervention
Transfemoral Amputation Device: OPRA Implant System

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Osseointegrated Prostheses for the Rehabilitation of Amputees.

Resource links provided by NLM:

Further study details as provided by Integrum:

Primary Outcome Measures:
  • Q-TFA Prosthetic Use Score [ Time Frame: 0,1,2,3,5,7,10,15,20 years ]
    The primary efficacy variable is the change in Q-TFA Prosthetic Use Score as compared baseline.

Enrollment: 51
Study Start Date: May 1999
Estimated Study Completion Date: May 2027
Estimated Primary Completion Date: May 2027 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Implant System Device: OPRA Implant System


Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Transfemoral amputation

Exclusion Criteria:

  • Transfemoral amputation due to vascular disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01725711

Sahlgrenska University Hospital
Gothenburg, VG, Sweden, 413 45
Sponsors and Collaborators
Sahlgrenska University Hospital, Sweden
Göteborg University
  More Information

Responsible Party: Integrum Identifier: NCT01725711     History of Changes
Other Study ID Numbers: R402-98
Study First Received: October 15, 2012
Last Updated: November 13, 2012 processed this record on August 18, 2017